- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06544096
Application Evaluation of Newborn Home Skin Care Management System Under the Service of "WeChat Platform+Health Care"
Evaluation of the Effectiveness of a Neonatal Home Skin Care Guidance Based on We-chat: A Cluster-Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
In this study, the cluster randomization method is used, and eight centers are assigned to the experimental group or the control group according to the ratio of 1:1. Randomization plan is made by independent statistical team in statistical software: by creating random seed numbers and sorting them, the intervention plan distribution of each center is determined. The outcome evaluator and the statistical analysis team will not know the grouping situation of each center.
In this study, there are 4 centers in the experimental group and 4 centers in the control group. Sample size calculation is based on the main outcome index: the incidence of diaper dermatitis in newborns at home.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201102
- Children's Hospital of Fudan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Newborns born in normal delivery (gestational age ≧35w)
- Newborns' parents can cooperate, have certain learning, reading and understanding abilities, and have the ability to care for newborns
- Voluntary participation in this study.
Exclusion Criteria:
- Newborns requiring hospitalization.
- Newborns diagnosed with congenital skin diseases.
- The newborn mother has mental illness.
- The newborn mother has a serious illness and needs hospitalization.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: the control group
Routine health education
|
When the parturient is discharged from the hospital, the medical staff of the control unit will give the parturient health education about the discharge of the newborn.
The contents of the education include neonatal jaundice, umbilical care, vaccination, 42-day follow-up, breastfeeding and so on, which are not included in the system.
|
|
Experimental: Using"WeChat platform+health care" group
Use"WeChat platform+health care"
|
The study will implement the WeChat-based Neonatal Home Skin Care Management System, designed based on neonatal skin characteristics and evidence-based care guidelines.
The intervention materials included a WeChat platform functional module (comprising a newborn information registration interface, online consultation, and questionnaire features) along with standard educational brochures used in the control group.
During hospitalization, study group healthcare providers will deliver standard health education (identical to the control group) while additionally guiding mothers through platform registration and data entry, with demonstrations of system functionality.
Post-discharge, the system automatically will deliver stage-appropriate skin care recommendations based on neonatal age with read reminders prompting parental engagement.
Parents can access educational materials or submit queries at any time, while researchers utilize the platform for survey distribution.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of diaper dermatitis in newborns at home
Time Frame: Within two months after birth
|
The proportion of people with diaper dermatitis in the total number of people in the study.The diagnosis of diaper dermatitis is based on any rash in the diaper area reported by parents.
|
Within two months after birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence rate of neonatal home atopic dermatitis (AD)
Time Frame: Within two months after birth
|
The proportion of people with atopic dermatitis (AD) in the total number of people in the study.The subjects reported by parents are itching, typical morphology and location (flexor dermatitis) or atypical morphology and location accompanied by xeroderma and chronic or recurrent course of disease; Have the above three items at the same time to diagnose.
|
Within two months after birth
|
|
Rate of Hospital Visits for Skin Problems
Time Frame: Within two months after birth
|
The rate of parent-initiated hospital visits for infant skin problems was calculated as the total number of visits for skin issues divided by the total number of newborns investigated during the study period.
|
Within two months after birth
|
|
Parental Knowledge of Home Skincare
Time Frame: Within two months after birth
|
Parental knowledge of home skincare was assessed using questionnaire scores on skin management knowledge
|
Within two months after birth
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hu Xiaojing, PhD, Children's Hospital of Fudan University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024/6/7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infants
-
Centre Hospitalier Universitaire de Saint EtienneENES, CNRS 9197Completed
-
Tel-Aviv Sourasky Medical CenterUnknownSmall for Gestational Age Infants | Appropriate for Gestational Age InfantsIsrael
-
Société des Produits Nestlé (SPN)CompletedSmall for Gestational Age (SGA) Infants | Appropriate for Gestational Age (AGA) InfantsIndia
-
Kahramanmaras Sutcu Imam UniversityRecruitingNICU | Family Centered Care | NICU Infants | Infants Admitted to Neonatal UnitsTurkey (Türkiye)
-
International Centre for Diarrhoeal Disease Research...Newcastle UniversityCompletedHealthy Infants | Infants With an Inflammatory ConditionBangladesh
-
Junlebao Dairy Group Co., Ltd.Merieux NutriSciences (China)Active, not recruiting
-
University of GlasgowCompletedMaltreated InfantsUnited Kingdom
-
NestléCompleted
Clinical Trials on control group (routine health education)
-
Fuyang Affiliated Hospital of Anhui Medical UniversityCompleted
-
Junyan ZhaoActive, not recruitingTumor Chemotherapy PatientsChina
-
Visiting Nurse Service of New YorkCompletedHeart Diseases | Cardiovascular Diseases | Hypertension
-
Tianjin HospitalCompletedLumbar Disc HerniationChina
-
Children's Hospital of Fudan UniversityNot yet recruiting
-
Tungs' Taichung Metroharbour HospitalRecruitingDepression | Breast Cancer | AnxietyTaiwan
-
West China HospitalWest China Fourth Hospital, Sichuan UniversityCompletedRadiotherapy; Complications | Malignant Tumor of Head and/or NeckChina
-
Rush University Medical CenterCompletedOsteoarthritis, Knee | Osteoarthritis, Hip
-
Yuanjiao YanCompletedChronic Obstructive Pulmonary Disease (COPD)China